Obatoclax Mesylate, Carboplatine and Etoposide
C41601/3099
Phase 3 small_molecule terminated
Quick answer
Obatoclax Mesylate, Carboplatine and Etoposide for Extensive-stage Small Cell Lung Cancer is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Extensive-stage Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated